Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-14

Clinical Trial Update: Natural Matrix Protein™ (NMP™) in Interbody Lumbar Fusion

View source ↗

Summary

A clinical trial evaluating Natural Matrix Protein (NMP) for interbody lumbar fusion in degenerative disc disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Natural Matrix Protein™ (NMP™)

Snippet

Sponsor: Induce Biologics USA Inc. | Conditions: Degenerative Disc Disease | Status: COMPLETED